David Rescott
Stock Analyst at Robert W. Baird
(3.87)
# 1,937
Out of 4,651 analysts
259
Total ratings
52%
Success rate
6.8%
Average return
Main Sectors:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Maintained: Buy | $67 → $96 | $90.80 | +5.73% | 7 | Aug 7, 2026 | |
| RMD ResMed | Maintained: Hold | $225 → $213 | $224.46 | -5.11% | 10 | Aug 7, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | $175 → $165 | $126.44 | +30.50% | 31 | Aug 7, 2026 | |
| NYXH Nyxoah | Maintained: Hold | $2.85 → $2.31 | $1.62 | +42.59% | 10 | Aug 6, 2026 | |
| TMDX TransMedics Group | Maintained: Buy | $140 → $122 | $88.58 | +37.73% | 8 | Aug 5, 2026 | |
| PRCT PROCEPT BioRobotics | Maintained: Hold | $28 → $20 | $21.65 | -7.62% | 3 | Aug 5, 2026 | |
| INSP Inspire Medical Systems | Maintained: Hold | $50 → $59 | $57.10 | +3.33% | 20 | Aug 4, 2026 | |
| MMSI Merit Medical Systems | Maintained: Buy | $83 → $98 | $90.76 | +7.98% | 14 | Jul 31, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $70 → $56 | $51.83 | +8.05% | 29 | Jul 30, 2026 | |
| HTFL HeartFlow | Initiated Coverage: Buy | $34 | $42.08 | -19.20% | 1 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $610 → $500 | $394.51 | +26.74% | 18 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $121 | $111.25 | +8.76% | 1 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $100 → $85 | $91.27 | -6.87% | 24 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $76 | $82.22 | -7.57% | 23 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $87 | $91.60 | -5.02% | 22 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $345 → $374 | $327.02 | +14.37% | 26 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $113.03 | n/a | 1 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $26 | $18.93 | n/a | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 | $100.65 | n/a | 1 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $24.80 | n/a | 1 | Dec 21, 2021 |
Haemonetics
Aug 7, 2026
Maintained: Buy
Price Target: $67 → $96
Current: $90.80
Upside: +5.73%
ResMed
Aug 7, 2026
Maintained: Hold
Price Target: $225 → $213
Current: $224.46
Upside: -5.11%
iRhythm Holdings
Aug 7, 2026
Maintained: Buy
Price Target: $175 → $165
Current: $126.44
Upside: +30.50%
Nyxoah
Aug 6, 2026
Maintained: Hold
Price Target: $2.85 → $2.31
Current: $1.62
Upside: +42.59%
TransMedics Group
Aug 5, 2026
Maintained: Buy
Price Target: $140 → $122
Current: $88.58
Upside: +37.73%
PROCEPT BioRobotics
Aug 5, 2026
Maintained: Hold
Price Target: $28 → $20
Current: $21.65
Upside: -7.62%
Inspire Medical Systems
Aug 4, 2026
Maintained: Hold
Price Target: $50 → $59
Current: $57.10
Upside: +3.33%
Merit Medical Systems
Jul 31, 2026
Maintained: Buy
Price Target: $83 → $98
Current: $90.76
Upside: +7.98%
Boston Scientific
Jul 30, 2026
Maintained: Buy
Price Target: $70 → $56
Current: $51.83
Upside: +8.05%
HeartFlow
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $42.08
Upside: -19.20%
Jul 17, 2026
Maintained: Buy
Price Target: $610 → $500
Current: $394.51
Upside: +26.74%
Jun 30, 2026
Initiated Coverage: Buy
Price Target: $121
Current: $111.25
Upside: +8.76%
Jun 4, 2026
Maintained: Hold
Price Target: $100 → $85
Current: $91.27
Upside: -6.87%
May 7, 2026
Maintained: Buy
Price Target: $83 → $76
Current: $82.22
Upside: -7.57%
Apr 24, 2026
Maintained: Hold
Price Target: $87
Current: $91.60
Upside: -5.02%
Jan 15, 2026
Downgraded: Hold
Price Target: $345 → $374
Current: $327.02
Upside: +14.37%
Apr 24, 2025
Maintained: Hold
Price Target: n/a
Current: $113.03
Upside: n/a
Feb 28, 2023
Maintained: Buy
Price Target: $17 → $26
Current: $18.93
Upside: n/a
Dec 21, 2021
Maintained: Buy
Price Target: $145
Current: $100.65
Upside: n/a
Dec 21, 2021
Maintained: Buy
Price Target: $75
Current: $24.80
Upside: n/a